Promising Innovations To Bend The AMR Curve (Part-I)
The emergent global threat of Antimicrobial Resistance (AMR) is in need of innovative ways to contain and control what is set to be the next epidemic. This requires combined multi-sectoral co-operation on different fronts. Scientific innovations have the potential to control AMR at source, either by early detection and identification of the pathogen, or by differential therapeutic approaches that offer alternatives to existing antimicrobials, and can also prevent development of microbial resistance. There are many noteworthy solutions in this domain of which CARB-X supported innovations by Module Innovations, Bugworks Research and Gangagen Biotechnologies stand out prominently from India.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.